UBS Reiterates Buy Rating for Quantinuum Inc. (QNT)
UBS maintains its buy rating for Quantinuum Inc., setting a price target of $93, a 13.78% upside from the current price.
Key Points
- UBS reiterated its buy rating on Quantinuum Inc. (QNT) with a price target of $93 as of June 29, 2026.
- UBS's $93 price target implies 13.78% upside from Quantinuum Inc.'s ($QNT) current $81.74 share price.
- Quantinuum's shares traded around $81.74 on Wednesday, with a market cap of $21.19 billion.
- Morgan Stanley, JP Morgan, and other firms also initiated coverage, with targets ranging from $78 to $155.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
UBS has reiterated its buy rating for Quantinuum Inc. (QNT) on June 29, 2026, maintaining a price target of $93. This affirmation comes as part of the latest analyst coverage of the quantum computing firm.
UBS vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Quantinuum Inc. Stock Up 63.7%
Shares of NasdaqGM:QNT traded near $81.74 on Wednesday. Quantinuum Inc. has a market cap of approximately $21.19 billion. The company isn't currently profitable, reflected by a negative forward P/E ratio of -52.22. It operates with a strong current ratio of 11.04 and a quick ratio of 10.66, indicating robust liquidity. Over the past year, the stock has seen a low of $50.10 and a high of $82.30, with a 50-day and 200-day moving average both around $63.29.
$QNT price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Quantinuum Inc.
Recent insider activity at Quantinuum Inc. shows several purchases made on June 5, 2026. Notable transactions include Michal Stepniak buying 13,333 shares, Joseph Jimenez acquiring 66,665 shares, and Chief Financial Officer Nitesh Sharan purchasing 6,500 shares, all at an average price of $60. These transactions were not part of a pre-arranged trading plan.
Analysts Set New Price Targets
On June 29, 2026, several firms initiated coverage on Quantinuum. Morgan Stanley started with a hold rating and a $78 target, while JP Morgan and Jefferies both issued buy ratings with targets of $97 and $90, respectively. Cantor Fitzgerald and Mizuho also set a target of $90 with a buy rating. Craig-Hallum provided the highest target at $100, and Rosenblatt set a notably high target of $155, both with buy ratings. The consensus target price among analysts is $93, based on nine opinions.
About Quantinuum Inc.
Quantinuum Inc. is a technology company specializing in quantum computing hardware and software. Based in Broomfield, Colorado, it develops a quantum computing platform that includes hardware systems, developer tools, and application libraries. Founded in 2021, the company aims to make quantum computing applicable to real-world scenarios. Led by CEO Nitesh Sharan, Quantinuum employs 679 people.
Bottom Line
UBS's reiteration of a buy rating with a $93 target highlights ongoing interest in Quantinuum's potential, despite its current lack of profitability. With multiple analysts initiating coverage and setting varied price targets, investor focus remains on the company's growth prospects in the quantum computing sector. Always remember that such analyst ratings are forward-looking and subject to change based on market conditions and company performance.
Get Quantinuum Inc. alerts
New 13F filings, insider trades, and analyst moves on $QNT, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
